Quantbot Technologies LP Invests $2.38 Million in UnitedHealth Group Incorporated $UNH

Key Points

• Quantbot Technologies LP acquired 4,535 shares of UnitedHealth Group, valued at approximately $2.375 million, marking a new investment in the stock.
• In the latest earnings report, UnitedHealth Group missed EPS estimates with $4.08 compared to the expected $4.45, while total revenue was $111.62 billion, slightly below estimates.
• The company recently announced a quarterly dividend of $2.21 per share, with a yield of 2.9% and an upcoming payout date of September 23rd.

Quantbot Technologies LP acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 4,535 shares of the healthcare conglomerate's stock, valued at approximately $2,375,000.

Several other hedge funds and other institutional investors have also modified their holdings of UNH. Brighton Jones LLC lifted its stake in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC lifted its position in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after acquiring an additional 2,324 shares in the last quarter. Harvest Investment Services LLC lifted its position in UnitedHealth Group by 21.7% during the 4th quarter. Harvest Investment Services LLC now owns 522 shares of the healthcare conglomerate's stock worth $264,000 after acquiring an additional 93 shares in the last quarter. MGO One Seven LLC lifted its position in UnitedHealth Group by 17.5% during the 4th quarter. MGO One Seven LLC now owns 8,751 shares of the healthcare conglomerate's stock worth $4,427,000 after acquiring an additional 1,306 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. lifted its position in UnitedHealth Group by 17.8% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 4,785,940 shares of the healthcare conglomerate's stock worth $2,421,016,000 after acquiring an additional 723,115 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.28% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

UNH has been the topic of several recent research reports. HSBC reissued a "reduce" rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Raymond James Financial lowered UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Baird R W lowered UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Oppenheimer cut their target price on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Finally, Mizuho cut their target price on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Fifteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average price target of $365.38.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $3.7480 during trading on Friday, reaching $307.0980. The stock had a trading volume of 14,867,565 shares, compared to its average volume of 23,516,492. The stock has a market cap of $278.13 billion, a PE ratio of 13.31, a P/E/G ratio of 1.96 and a beta of 0.43. The firm's 50 day moving average price is $288.39 and its two-hundred day moving average price is $389.57. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio is presently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.